Our findings identify YBX1 as a promoter of lung FMT via the PTBP1/PTPN1 axis, offering mechanistic insights for the development of YBX1-targeted therapeutic strategies for IPF. The gene discussed is YBX1; the disease is idiopathic pulmonary fibrosis.